Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom s Q1 Revenues Surge, Losses Halved

This article has been updated from a previous version, which had the incorrect percentage increase in the first paragraph.


NEW YORK, May 5 (GenomeWeb News) - Sequenom yesterday reported a 61-percent jump in first-quarter revenues and a dramatic reduction in net losses.


For the quarter ended March 31, Sequenom's revenues increased to $6.9 million from $4.3 million in the first quarter of 2005.


The company's net loss for the first quarter was $3.7 million, or $.09 per share, compared to $7.4 million, or $.19 per share for the first quarter of 2005.


Sequenom cut its R&D spending to $2.5 million from $3.3 million in the first quarter of 2005.


On March 31, the company had available cash and short-term investments of $2.9 million.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.